Van Delft P, Lenters E, Bakker-Verweij M, de Korte M, Baylan U, Harteveld C L, Giordano P C
The Haemoglobinopathies Laboratory, Department of Human and Clinical Genetics, Leiden University Medical Centre, Leiden 2300 RC, The Netherlands.
Int J Lab Hematol. 2009 Oct;31(5):484-95. doi: 10.1111/j.1751-553X.2009.01158.x. Epub 2009 Apr 17.
We have tested five haemoglobin (Hb) separation apparatuses, dedicated to haemoglobinopathy diagnostics. These are the four high performance liquid chromatography devices: VARIANT II, HA 8160, G7, Ultra(2) and the Capillary Electrophoresis apparatus from Sebia. In the first place, we focussed on the capacity of all apparatuses to detect the most common structural variants relevant for public health, these being HbS, HbC, HbE, HbD-Punjab and HbO-Arab. We then compared how the high HbA(2)beta-thalassaemia carriers were identified. All apparatuses were able to identify carriers of these traits with the expected sensitivity and specificity. With the primary goal of a high degree of conformity in basic diagnostics of haemoglobinopathies, we present the interpretation and the significance of the results on all apparatuses, and we comment on the unavoidable problems and solutions.
我们测试了五台用于血红蛋白病诊断的血红蛋白(Hb)分离仪器。它们是四台高效液相色谱设备:VARIANT II、HA 8160、G7、Ultra(2) 以及赛比亚公司的毛细管电泳仪。首先,我们重点关注了所有仪器检测与公共卫生相关的最常见结构变异体的能力,这些变异体包括HbS、HbC、HbE、HbD - 旁遮普和HbO - 阿拉伯。然后,我们比较了各仪器识别高HbA(2)β地中海贫血携带者的方式。所有仪器都能够以预期的灵敏度和特异性识别这些特征的携带者。为了在血红蛋白病的基本诊断中实现高度一致性这一主要目标,我们展示了所有仪器检测结果的解读及意义,并对不可避免的问题及解决方案进行了评论。